Cargando…

Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation

Glucocorticoid (GC) resistance is a crucial determinant of inferior response to chemotherapy in pediatric acute lymphoblastic leukemia (ALL); however, molecular mechanisms underlying this phenomenon are poorly understood. Deregulated splicing is a common feature of many cancers, which impacts drug r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sciarrillo, Rocco, Wojtuszkiewicz, Anna, Kooi, Irsan E., Leon, Leticia G., Sonneveld, Edwin, Kuiper, Roland P., Jansen, Gerrit, Giovannetti, Elisa, Kaspers, Gertjan J.L., Cloos, Jacqueline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140081/ https://www.ncbi.nlm.nih.gov/pubmed/32204435 http://dx.doi.org/10.3390/cancers12030723

Ejemplares similares

Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia
por: Wojtuszkiewicz, Anna, et al.
Publicado: (2015)

SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
por: van der Werf, Inge, et al.
Publicado: (2021)

Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
por: Sciarrillo, Rocco, et al.
Publicado: (2018)

(Immuno)proteasomes as therapeutic target in acute leukemia
por: Cloos, Jacqueline, et al.
Publicado: (2017)

P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR SENSITIVITY TO BORTEZOMIB-CONTAINING CHEMOTHERAPY IN ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS FROM CHILDREN’S ONCOLOGY GROUP TRIAL AALL1231
por: Roeten, Margot, et al.
Publicado: (2023)

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells
por: Roeten, Margot S.F., et al.
Publicado: (2021)

The spliceosome is a therapeutic vulnerability in MYC-driven cancer
por: Hsu, Tiffany Y-T., et al.
Publicado: (2015)

Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines
por: Niewerth, Denise, et al.
Publicado: (2014)

Impaired sleep affects quality of life in children during maintenance treatment for acute lymphoblastic leukemia: an exploratory study
por: van Litsenburg, Raphaële RL, et al.
Publicado: (2011)

Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
por: Chougule, Rohit A., et al.
Publicado: (2019)

A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression
por: Kooi, Irsan E., et al.
Publicado: (2016)

Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells
por: Blijlevens, Maxime, et al.
Publicado: (2020)

Spliceosome Database: a tool for tracking components of the spliceosome
por: Cvitkovic, Ivan, et al.
Publicado: (2013)

Computational comparison of common event-based differential splicing tools: practical considerations for laboratory researchers
por: Muller, Ittai B., et al.
Publicado: (2021)

Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors
por: Shi, Yao, et al.
Publicado: (2021)

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma
por: Gelli, Elisa, et al.
Publicado: (2023)

Loss of photoreceptorness and gain of genomic alterations in retinoblastoma reveal tumor progression
por: Kooi, Irsan E., et al.
Publicado: (2015)

Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes
por: Kooi, Irsan E., et al.
Publicado: (2016)

Trimethylation of H3K27 during human cerebellar development in relation to medulloblastoma
por: Mir, Shahryar E., et al.
Publicado: (2017)

Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis
por: Muller, Ittai B, et al.
Publicado: (2020)

Structures of the human pre-catalytic spliceosome and its precursor spliceosome
por: Zhan, Xiechao, et al.
Publicado: (2018)

Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma
por: Huang, Hector H., et al.
Publicado: (2020)

Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
por: Zhang, Dingxiao, et al.
Publicado: (2020)

Somatic Mutations in Core Spliceosome Components Promote Tumorigenesis and Generate an Exploitable Vulnerability in Human Cancer
por: Sette, Claudio, et al.
Publicado: (2022)

Human spliceosomal snRNA sequence variants generate variant spliceosomes
por: Mabin, Justin W., et al.
Publicado: (2021)

Spliceosome assembly and regulation: insights from analysis of highly reduced spliceosomes
por: Black, Corbin S., et al.
Publicado: (2023)

Challenging the spliceosome machine
por: Weir, Michael, et al.
Publicado: (2006)

Structure of spliceosomal ribonucleoproteins
por: Krummel, Daniel Aaron Pomeranz, et al.
Publicado: (2010)

Health-related quality of life and utility scores in short-term survivors of pediatric acute lymphoblastic leukemia
por: van Litsenburg, Raphaële R. L., et al.
Publicado: (2012)

CryoEM structures of two spliceosomal complexes: starter and dessert at the spliceosome feast
por: Nguyen, Thi Hoang Duong, et al.
Publicado: (2016)

Patterns of conservation of spliceosomal intron structures and spliceosome divergence in representatives of the diplomonad and parabasalid lineages
por: Hudson, Andrew J., et al.
Publicado: (2019)

The spliceosome as target for anticancer treatment
por: van Alphen, R J, et al.
Publicado: (2009)

Origin and evolution of spliceosomal introns
por: Rogozin, Igor B, et al.
Publicado: (2012)

Spliceosome Mutations in Uveal Melanoma
por: Nguyen, Josephine Q.N., et al.
Publicado: (2020)

Spliceosomal snRNA Epitranscriptomics
por: Morais, Pedro, et al.
Publicado: (2021)

The impact of spliceosome mutations in MDS
por: Boultwood, Jacqueline, et al.
Publicado: (2019)

Harnessing Gene Expression Profiles for the Identification of Ex Vivo Drug Response Genes in Pediatric Acute Myeloid Leukemia
por: Cucchi, David G.J., et al.
Publicado: (2020)

Positioning of proteasome inhibitors in therapy of solid malignancies
por: Roeten, Margot S. F., et al.
Publicado: (2017)

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
por: Niewerth, Denise, et al.
Publicado: (2016)

An efficient method for the transduction of primary pediatric glioma neurospheres
por: Meel, Michaël H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_df360i7dl4clisnjsam0qt7v3d